Inventor
GOOD ANDREW CHARLES
US18 patents
⚠️ This page may combine multiple inventors who share the name “GOOD ANDREW CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
10 patentsUS7449479B2Nov 11, 2008
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO67 citations99
US6867185B2Mar 15, 2005
Inhibitors of hepatitis C virus
BRISTOL MYERS SQUIBB CO153 citations99
US6995174B2Feb 7, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO194 citations98
US6869964B2Mar 22, 2005
Heterocyclicsulfonamide hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO134 citations98
US7173004B2Feb 6, 2007
Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
BRISTOL MYERS SQUIBB CO90 citations97
US7041698B2May 9, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO135 citations97
US7741281B2Jun 22, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO20 citations92
US7323447B2Jan 29, 2008
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO50 citations92
US7309708B2Dec 18, 2007
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO39 citations92
US7592336B2Sep 22, 2009
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
C4 THERAPEUTICS INC
4 patentsUS11407732B1Aug 9, 2022
Tricyclic degraders of Ikaros and Aiolos
C4 THERAPEUTICS INC10 citations85
US11753397B2Sep 12, 2023
Cereblon binders for the degradation of ikaros
C4 THERAPEUTICS INC1 citations62
US12559492B2Feb 24, 2026
BRAF degraders
C4 THERAPEUTICS INC0 citations48
US12421220B2Sep 23, 2025
Bicyclic-substituted glutarimide cereblon binders
C4 THERAPEUTICS INC0 citations47
GENENTECH INC
4 patentsUS10308614B2Jun 4, 2019
Therapeutic compounds and uses thereof
GENENTECH INC4 citations73
US10358437B2Jul 23, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US10301253B2May 28, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US10155764B2Dec 18, 2018
Therapeutic compounds and uses thereof
GENENTECH INC0 citations40